RecruitingNCT04808596
Pulmonary Hypertension Biorepository and Registry
Sponsor
University of Kansas Medical Center
Enrollment
300 participants
Start Date
Aug 10, 2020
Study Type
OBSERVATIONAL
Conditions
Pulmonary HypertensionPulmonary Arterial HypertensionPulmonary Hypertension Due to Lung Diseases and HypoxiaChronic Thromboembolic Pulmonary HypertensionPulmonary Hypertension Due to Left Heart DiseasePulmonary Hypertension, PrimaryPulmonary Hypertension, Primary, 4Pulmonary Hypertension, Primary, 2Pulmonary Hypertension, Primary, 3
Summary
Establish a pulmonary hypertension registry and biorepository to lead towards a further understanding of the disease.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- The participant is a patient at TUKHS or has agreed to participate in a study approved by the KUMC Human Research Protection Program (HRPP)
- The participant has a diagnosis of pulmonary hypertension confirmed by right heart catheterization
- Patient is ≥ 18 years of age or older
Exclusion Criteria2
- Participant declines to participate (living patients only)
- Participant is unable to provide informed consent (living patients only)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04808596
Related Trials
A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension
NCT065543011 location
Development of Novel Physiological CMR Methods in Health and Disease
NCT038540711 location
A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489
NCT0707382036 locations
Natural History Study of Biomarkers in Pulmonary Arterial Hypertension
NCT017300921 location
Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
NCT074771971 location